# Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes

Study · id `cardio:ct-nct02513303` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02513303](<https://clinicaltrials.gov/study/NCT02513303>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02513303

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 269 participants.

## Technical summary

Registry record NCT02513303. Randomized; triple masking; primary purpose prevention. Start 2015-11 (registry gives no type); primary completion 2021-06 (actual). Results posted on 2025-10-09.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 269 participants (enrolled count; ClinicalTrials.gov record NCT02513303, source copy `cardio:ctgov-nct02513303-2025-10-09`, retrieved 2026-10-26)
- Start date: 2015-11 (registry gives no type) (ClinicalTrials.gov record NCT02513303, source copy `cardio:ctgov-nct02513303-2025-10-09`, retrieved 2026-10-26)
- Primary completion: 2021-06 (actual) (ClinicalTrials.gov record NCT02513303, source copy `cardio:ctgov-nct02513303-2025-10-09`, retrieved 2026-10-26)
- Completion: 2021-06 (actual) (ClinicalTrials.gov record NCT02513303, source copy `cardio:ctgov-nct02513303-2025-10-09`, retrieved 2026-10-26)
- Results first posted: 2025-10-09 (ClinicalTrials.gov record NCT02513303, source copy `cardio:ctgov-nct02513303-2025-10-09`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02513303, source copy `cardio:ctgov-nct02513303-2025-10-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02513303-2025-10-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
- Acronym: ACCESS
- Condition: Complication of Renal Dialysis
- Condition: End Stage Renal Disease
- Condition: End Stage Kidney Disease
- Condition: ESRD
- Condition: Chronic Kidney Failure
- Condition: Complication of Hemodialysis
- Condition: Vascular Access Complication
- Condition: Arteriovenous Fistula
- Intervention (Drug): Sirolimus
- Intervention (Procedure): AV Fistula Surgery
- Intervention (Device): Sirolimus-eluting Collagen Implant (SeCI)
- Lead sponsor: Vascular Therapies, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 748edbe67b094d2ab4b6ff1af8eb246c83f5c4ba1e8ad8959230e7e96332de1a
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
